News
Category
-
GlobeNewswire
Acacia Pharma Announces Initiation of Pivotal Study of Byfavo® in Pediatric Procedural Sedation
September 16, 2021 -
Business Wire
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2 Clinical Trial of XTX101 for the Treatment of Patients with Solid Tumors
September 16, 2021 -
GlobeNewswire
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
September 16, 2021 -
GlobeNewswire
Pulmocide’s lead drug candidate opelconazole (PC945) granted Orphan Drug, Fast Track and Qualified Infectious Disease Product Designations by US FDA
September 15, 2021 -
Business Insider India
IPO-bound online pharmacy startup PharmEasy makes its third big acquisition this year
September 15, 2021 -
GlobeNewswire
Owkin Enters Into Agreement to Build Innovative Methods With the Potential to Enhance AI-Enabled External Control Arms
September 15, 2021 -
PR Newswire
Benchling Expands into Early Development Market to Accelerate Delivery of Breakthrough Products
September 14, 2021 -
Business Wire
Kyruus Broadens its Online Scheduling Platform to Allow Consumers to Self-Book Diagnostic and Preventive Care Appointments
September 14, 2021 -
GlobeNewswire
Orchard Therapeutics Outlines Differentiated Profile of Its HSC Gene Therapy Approach and Discusses Potential Future Applications at Virtual R&D Investor Event
September 14, 2021 -
Business Wire
Proximie Selects 8×8 Call and Video Quality Performance Monitoring to Enhance Future of Surgical Healthcare
September 14, 2021 -
GlobeNewswire
Adaptimmune Announces Clinical Responses across Five Solid Tumor Indications with an Overall Response Rate of 36% and Promising Early Durability from its Next-Generation SURPASS Trial
September 13, 2021 -
Reuters
Restaurant-software provider Toast aims for over $16 bln valuation in U.S. IPO
September 13, 2021 -
PR Newswire
Dr. Patrice Harris Joins Quartet Health’s Board of Directors
September 10, 2021 -
PR Newswire
RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels
September 9, 2021 -
GlobeNewswire
Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS
September 9, 2021 -
GlobeNewswire
Inovia Capital Partner and Former RIM CFO and COO Dennis Kavelman Joins BenchSci Board of Directors
September 9, 2021 -
GlobeNewswire
Flywire Announces Flywire Forward, a Virtual Event Focused on the Future of FinTech
September 9, 2021 -
PR Newswire
Proximie Partners with Teladoc Health to Connect Operating Rooms Globally
September 9, 2021 -
Business Wire
Precision BioSciences and iECURE Announce License and Collaboration Agreement to Develop ARCUS-Based Gene Editing Therapies
September 9, 2021 -
PR Newswire
Huadong Medicine and Insilico Medicine enter co-development partnership to advance oncology drug discovery by hitting undruggable targets
September 8, 2021 -
PR Newswire
Snapsheet Joins NVIDIA Inception to Accelerate the Development of AI Models that Automate Claims Management Processes for Insurers
September 8, 2021 -
GlobeNewswire
Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment of Neurologic and Neuro-oncologic Diseases supported by Multi-Year Manufacturing Agreement with Lonza Group
September 8, 2021 -
PR Newswire
SoulBeing Joins Buoy Health’s Marketplace to Offer Alternative Medicine Services to Consumers
September 7, 2021 -
PR Newswire
Insilico Medicine and University of Cambridge Announce a Collaboration on Target Identification for Human Diseases Linked to Protein Liquid-liquid Phase Separation
September 7, 2021 -
PR Newswire
Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China
September 7, 2021 -
GlobeNewswire
Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit
September 5, 2021 -
Business Wire
Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment
September 2, 2021 -
GlobeNewswire
One Medical Completes Acquisition of Iora Health
September 1, 2021 -
PR Newswire
Insilico Medicine Collaborates with Gray Matter to Fight Age-related Cognitive Decline
September 1, 2021 -
PR Newswire
Benchling Names Salesforce Executive Lindsey Irvine as Chief Marketing Officer
September 1, 2021 -
PR Newswire
Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)
September 1, 2021 -
TechCrunch
Oviva grabs $80M for app-delivered healthy eating programs
September 1, 2021 -
Fierce Healthcare
AppliedVR taps Curebase to run at-home clinical trials testing VR for pain treatment
August 31, 2021 -
Business Wire
Nocion Therapeutics Announces Dosing Underway in Participants with Chronic Cough
August 31, 2021 -
FierceBiotech
Insilico Medicine taps 4B Technologies’ neurological know-how to build AI-designed ALS drugs
August 27, 2021 -
GlobeNewswire
Denali Therapeutics Announces Publication in Cell on New Approach to Treat FTD-GRN
August 26, 2021 -
GlobeNewswire
Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors
August 26, 2021 -
PR Newswire
NYCM Insurance Launches Snapsheet Payments Software to Enable Digital Payment Options for Claimants and Vendors
August 26, 2021 -
GlobeNewswire
Ultragenyx Announces Approval of Dojolvi® (triheptanoin) in Brazil for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Adults and Children
August 23, 2021 -
GlobeNewswire
Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)
August 19, 2021 -
Business Wire
NFlection Therapeutics Announces Orphan Drug Designation of NFX-179 for the Treatment of Cutaneous Neurofibromatosis Type 1
August 18, 2021 -
GlobeNewswire
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
August 18, 2021 -
Forbes
Fertility Startup Carrot Raises $75 Million In A Series C Round
August 17, 2021 -
GlobeNewswire
Flywire Survey: Majority of Americans Want Consumer-Friendly Ways to Pay for Healthcare
August 17, 2021 -
PR Newswire
Branch Insurance Partners with Snapsheet Claims Platform to Accelerate the Claims Experience
August 17, 2021 -
Business Wire
Xilio Therapeutics Appoints Sara Bonstein to Its Board of Directors
August 17, 2021 -
Endpoints News
As US review of Eli Lilly-partnered PD-1 gets underway, Innovent touts another frontline win in China
August 16, 2021 -
PR Newswire
Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use
August 16, 2021 -
PR Newswire
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
August 15, 2021 -
Business Wire
Innovusion Raises $66 Million in Series B Plus Financing to Accelerate the Global Adoption of Autonomous Transportation
August 13, 2021 -
PR Newswire
Vanessa Ribreau Joins BenchSci as Chief People Officer to Lead Company’s Embrace of the Future of Work
August 11, 2021 -
PR Newswire
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director
August 11, 2021 -
PR Newswire
1upHealth Announces Free Baseline Testing for Health Plans to Determine if their Patient Access FHIR® API is Successfully Connecting as Required by CMS
August 11, 2021 -
PR Newswire
Whatfix Closes Nittio Learn Acquisition During Record Quarter in Q2, 2021
August 10, 2021 -
Forbes
Beam Therapeutics Is Aiming To Start Human Trials For Its Sickle Cell Treatment
August 10, 2021 -
Business Wire
WellAir Appoints Kari Dixon as Chief Financial Officer
August 10, 2021 -
PR Newswire
MaxCyte Signs Clinical and Commercial License with Sana Biotechnology
August 9, 2021 -
PR Newswire
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
August 9, 2021 -
GlobeNewswire
Tempest Announces Appointment of Ronit Simantov, M.D. to its Board of Directors
August 9, 2021 -
PR Newswire
Innovent Announces the Establishment of the Scientific Advisory Board
August 8, 2021 -
GlobeNewswire
BenchSci Announces Craig Newell as New Chief Architect Officer as it Broadens Biomedical AI Platform
August 6, 2021 -
PR Newswire
EY Announces Nick Culbertson of Protenus as an Entrepreneur Of The Year® 2021 Mid-Atlantic Award Winner
August 5, 2021 -
PR Newswire
Insilico Medicine and Usynova Announce Strategic Partnership on Accelerating R&D of Small Molecule Innovative Drugs with AI
August 5, 2021 -
PR Newswire
Health Payment Systems, Inc. Names Centivo as a Third-Party Administrator for BHCG Member-Employers
August 4, 2021 -
FierceBiotech
Insilico Medicine’s AI engines continue to churn out new drug candidates, now in kidney fibrosis
August 4, 2021 -
PR Newswire
Buoy Health Publishes White Paper on Post-Pandemic Transformation of U.S. Healthcare Navigation
August 3, 2021 -
PR Newswire
Insilico Medicine and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus
August 2, 2021 -
GlobeNewswire
Cytek Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 2, 2021 -
Business Wire
Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
August 2, 2021 -
Venture Beat
MoEngage raises $32.5M to inject customer engagement with AI
July 30, 2021 -
GlobeNewswire
Flywire Digitizes Education Payments for LaLiga Business School
July 28, 2021 -
PR Newswire
BenchSci Extends Impact on Drug Discovery With Addition of AI-Assisted Animal Model Selection
July 28, 2021 -
Fierce Healthcare
Behavioral health matchmaker SonderMind hits unicorn status with $150M series C
July 28, 2021 -
PR Newswire
AvantStay Continues Market Expansion and Rapid Portfolio Growth Offering 600+ Homes Across the United States
July 27, 2021 -
GlobeNewswire
Cytek Biosciences Announces Closing of Its Initial Public Offering
July 27, 2021 -
PR Newswire
RareStone Inc. Announces Strategic Collaboration with Tencent on a Service Ecosystem Focused on Rare Disease Patients in China
July 27, 2021 -
Business Wire
LTC ACO Selects PatientPing’s Real-Time E-Notification System to Improve Patient Outcomes and Lower Total Cost of Care for Medicare Beneficiaries Across the Healthcare Continuum
July 27, 2021 -
PR Newswire
Embark Veterinary Announces $75M Series B Funding Led by SoftBank Vision Fund 2
July 26, 2021 -
GlobeNewswire
Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with the Lysosomal Storage Disease Hunter Syndrome (MPS II)
July 25, 2021 -
PR Newswire
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors
July 25, 2021 -
Renaissance Capital Report
Cell analysis instruments provider Cytek BioSciences prices upsized IPO at $17 midpoint
July 24, 2021 -
BioPharma Dive
Caribou raises $304M in one of gene editing’s most lucrative IPOs
July 23, 2021 -
Forbes
Warmly Launches Free App For Zoom, Announces Fresh $2.4 Million In Additional Funding
July 22, 2021 -
Nasdaq
Rare disease biotech Rallybio sets terms for $81 million IPO
July 22, 2021 -
GlobeNewswire
Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)
July 22, 2021 -
PR Newswire
RareStone Inc. Announces Submission of New Drug Application (NDA) of Wakix® (pitolisant) for narcolepsy with and without cataplexy in China
July 21, 2021 -
GlobeNewswire
Coherus BioSciences Names Physician-Scientist Ildiko Csiki, M.D., Ph.D., Chair of its Scientific Advisory Board
July 21, 2021 -
PR Web
Vestwell Raises $70 Million in Series C Funding, Led by Wells Fargo Strategic Capital and Fin Venture Capital
July 20, 2021 -
GlobeNewswire
Affinia Therapeutics Announces Collaboration with the Institute of Molecular and Clinical Ophthalmology Basel (IOB) To Rationally Design Novel CNS Promoters for Gene Therapy
July 20, 2021 -
PR Newswire
GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership
July 20, 2021